11/18
09:13 am
cor
CENCORA PRIVACY BREACH CLASS ACTION [Yahoo! Finance]
Low
Report
CENCORA PRIVACY BREACH CLASS ACTION [Yahoo! Finance]
11/14
04:19 pm
cor
$250B Cencora Names Pawan Verma Chief Data And Information Officer [Forbes]
Low
Report
$250B Cencora Names Pawan Verma Chief Data And Information Officer [Forbes]
11/13
05:32 pm
cor
Antacids Market to Grow by USD 692.3 Million (2024-2028), Driven by Rising Geriatric Population, AI-Powered Report Explores Market Evolution - Technavio [Yahoo! Finance]
Low
Report
Antacids Market to Grow by USD 692.3 Million (2024-2028), Driven by Rising Geriatric Population, AI-Powered Report Explores Market Evolution - Technavio [Yahoo! Finance]
11/13
12:00 pm
cor
Baltimore wins $266 million in opioid case against distributors [Yahoo! Finance]
Low
Report
Baltimore wins $266 million in opioid case against distributors [Yahoo! Finance]
11/13
12:00 pm
cor
Baltimore wins $266 million in opioid case against distributors [Yahoo! Finance Canada]
Low
Report
Baltimore wins $266 million in opioid case against distributors [Yahoo! Finance Canada]
11/13
09:55 am
cor
U.S. Veterinary Surgical Disposables Market Report 2025-2030, Featuring VeterSut, B. Braun Vet Care, Vitrex Medical, AmerisourceBergen, Med-Vet International, Genia, Covetrus, Vedco and Phoenix Suture [Yahoo! Finance]
Low
Report
U.S. Veterinary Surgical Disposables Market Report 2025-2030, Featuring VeterSut, B. Braun Vet Care, Vitrex Medical, AmerisourceBergen, Med-Vet International, Genia, Covetrus, Vedco and Phoenix Suture [Yahoo! Finance]
11/12
03:30 pm
cor
2 drug companies to pay $260M after jury finds them liable for city's opioid crisis [CBS News]
Low
Report
2 drug companies to pay $260M after jury finds them liable for city's opioid crisis [CBS News]
11/7
01:41 pm
cor
Cencora, Inc. (NYSE: COR) had its price target raised by analysts at Robert W. Baird from $287.00 to $292.00. They now have an "outperform" rating on the stock.
Low
Report
Cencora, Inc. (NYSE: COR) had its price target raised by analysts at Robert W. Baird from $287.00 to $292.00. They now have an "outperform" rating on the stock.
11/7
11:20 am
cor
Cencora, Inc. (NYSE: COR) had its price target raised by analysts at UBS Group AG from $275.00 to $285.00. They now have a "buy" rating on the stock.
Low
Report
Cencora, Inc. (NYSE: COR) had its price target raised by analysts at UBS Group AG from $275.00 to $285.00. They now have a "buy" rating on the stock.
11/7
09:51 am
cor
Cencora, Inc. (NYSE: COR) had its price target raised by analysts at Barclays PLC from $263.00 to $290.00. They now have an "overweight" rating on the stock.
Low
Report
Cencora, Inc. (NYSE: COR) had its price target raised by analysts at Barclays PLC from $263.00 to $290.00. They now have an "overweight" rating on the stock.
11/7
09:00 am
cor
Cencora, Inc. (NYSE: COR) had its price target raised by analysts at Evercore ISI from $250.00 to $285.00. They now have an "outperform" rating on the stock.
Low
Report
Cencora, Inc. (NYSE: COR) had its price target raised by analysts at Evercore ISI from $250.00 to $285.00. They now have an "outperform" rating on the stock.
11/6
06:37 am
cor
Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results [Yahoo! Finance]
Medium
Report
Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results [Yahoo! Finance]
11/6
06:35 am
cor
Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
Medium
Report
Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
11/6
06:30 am
cor
Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
Medium
Report
Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
11/4
08:30 am
cor
Cencora Expands Enterprise Leadership Team with Two Senior Appointments
Low
Report
Cencora Expands Enterprise Leadership Team with Two Senior Appointments
10/8
01:39 pm
cor
Cencora, Inc. (NYSE: COR) had its price target lowered by analysts at Evercore ISI from $270.00 to $250.00. They now have an "outperform" rating on the stock.
Low
Report
Cencora, Inc. (NYSE: COR) had its price target lowered by analysts at Evercore ISI from $270.00 to $250.00. They now have an "outperform" rating on the stock.
10/7
09:17 am
cor
Cencora, Inc. (NYSE: COR) had its price target lowered by analysts at Leerink Partners from $277.00 to $275.00. They now have an "outperform" rating on the stock.
Low
Report
Cencora, Inc. (NYSE: COR) had its price target lowered by analysts at Leerink Partners from $277.00 to $275.00. They now have an "outperform" rating on the stock.
10/1
07:30 am
cor
Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release
Low
Report
Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release
9/20
11:31 pm
cor
Cencora, Inc. (NYSE: COR) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
Cencora, Inc. (NYSE: COR) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
9/18
08:05 am
cor
Cencora, Inc. (NYSE: COR) had its "neutral" rating re-affirmed by analysts at Bank of America Co.. They now have a $245.00 price target on the stock, down previously from $275.00.
Low
Report
Cencora, Inc. (NYSE: COR) had its "neutral" rating re-affirmed by analysts at Bank of America Co.. They now have a $245.00 price target on the stock, down previously from $275.00.
9/10
08:00 am
cor
Frazier Healthcare Partners Adds Highly Experienced Pharma Executive to Growth Buyout Team
Low
Report
Frazier Healthcare Partners Adds Highly Experienced Pharma Executive to Growth Buyout Team
9/6
08:08 am
cor
Cencora, Inc. (NYSE: COR) had its price target lowered by analysts at Robert W. Baird from $287.00 to $283.00. They now have an "outperform" rating on the stock.
Low
Report
Cencora, Inc. (NYSE: COR) had its price target lowered by analysts at Robert W. Baird from $287.00 to $283.00. They now have an "outperform" rating on the stock.